Caprock Group LLC Buys 6,274 Shares of Cardinal Health, Inc. $CAH

Key Points

• Caprock Group LLC raised its stake in Cardinal Health by 41.6%, buying an additional 6,274 shares to own 21,373 shares worth $4.392 million at the end of the quarter.
• Cardinal Health beat expectations in the latest quarter with $2.63 EPS (vs. $2.31 est.) and $65.63 billion in revenue, up 18.8% year‑over‑year.
• Shares trade around $204.90; analysts rate the stock a consensus "Moderate Buy" with a $244.33 price target, and the company pays a $2.04 annual dividend (≈1.0% yield).

Caprock Group LLC raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 41.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,373 shares of the company's stock after buying an additional 6,274 shares during the period. Caprock Group LLC's holdings in Cardinal Health were worth $4,392,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Aventura Private Wealth LLC bought a new position in shares of Cardinal Health in the fourth quarter worth about $25,000. SJS Investment Consulting Inc. increased its stake in Cardinal Health by 1,363.6% during the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company's stock valued at $25,000 after acquiring an additional 150 shares during the period. Barnes Dennig Private Wealth Management LLC increased its stake in Cardinal Health by 38.7% during the fourth quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company's stock valued at $39,000 after acquiring an additional 53 shares during the period. JPL Wealth Management LLC acquired a new stake in Cardinal Health during the third quarter valued at approximately $31,000. Finally, Turning Point Benefit Group Inc. acquired a new stake in Cardinal Health during the third quarter valued at approximately $31,000. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Up 2.2%

Shares of CAH stock opened at $204.90 on Friday. Cardinal Health, Inc. has a 12-month low of $133.48 and a 12-month high of $233.60. The firm has a 50 day moving average price of $215.95 and a two-hundred day moving average price of $203.93. The company has a market capitalization of $48.22 billion, a PE ratio of 29.48, a price-to-earnings-growth ratio of 1.29 and a beta of 0.64.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, beating analysts' consensus estimates of $2.31 by $0.32. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company had revenue of $65.63 billion during the quarter, compared to the consensus estimate of $64.88 billion. During the same period in the previous year, the business earned $1.93 earnings per share. The firm's quarterly revenue was up 18.8% on a year-over-year basis. As a group, research analysts expect that Cardinal Health, Inc. will post 10.32 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date was Wednesday, April 1st. Cardinal Health's dividend payout ratio is presently 29.35%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CAH. Leerink Partners reaffirmed an "outperform" rating and set a $275.00 price objective on shares of Cardinal Health in a report on Monday, March 9th. JPMorgan Chase & Co. lifted their price objective on Cardinal Health from $209.00 to $243.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 10th. Wall Street Zen cut shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research report on Sunday, April 12th. Robert W. Baird set a $252.00 target price on shares of Cardinal Health in a research report on Friday, February 6th. Finally, Evercore dropped their price objective on Cardinal Health from $260.00 to $240.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 8th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $244.33.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.